Medical Care
Visceral Pain Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 546999
- Pages: 87
- Figures: 158
- Views: 3
The global market for Visceral Pain Treatment was estimated to be worth US$ 13430 million in 2023 and is forecast to a readjusted size of US$ 19220 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Visceral Pain Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Visceral Pain Treatment by region & country, by Type, and by Application.
The Visceral Pain Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Visceral Pain Treatment.
Market Segmentation
By Company
Addex Therapeutics Ltd
Astellas Pharma Inc.
Chromocell Corporation
GIcare Pharma Inc
Grunenthal GmbH
Medestea Research & Production S.p.A.
Neurim Pharmaceuticals Ltd
Pfizer Inc.
Segment by Type:
HS-665
CC-8464
BLU-5937
APD-371
Others
Segment by Application
In-patient
Out-patient
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Visceral Pain Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Visceral Pain Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Visceral Pain Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Visceral Pain Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Visceral Pain Treatment by region & country, by Type, and by Application.
The Visceral Pain Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Visceral Pain Treatment.
Market Segmentation
By Company
Addex Therapeutics Ltd
Astellas Pharma Inc.
Chromocell Corporation
GIcare Pharma Inc
Grunenthal GmbH
Medestea Research & Production S.p.A.
Neurim Pharmaceuticals Ltd
Pfizer Inc.
Segment by Type:
HS-665
CC-8464
BLU-5937
APD-371
Others
Segment by Application
In-patient
Out-patient
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Visceral Pain Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Visceral Pain Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Visceral Pain Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Visceral Pain Treatment Product Introduction
1.2 Global Visceral Pain Treatment Market Size Forecast
1.3 Visceral Pain Treatment Market Trends & Drivers
1.3.1 Visceral Pain Treatment Industry Trends
1.3.2 Visceral Pain Treatment Market Drivers & Opportunity
1.3.3 Visceral Pain Treatment Market Challenges
1.3.4 Visceral Pain Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Visceral Pain Treatment Players Revenue Ranking (2023)
2.2 Global Visceral Pain Treatment Revenue by Company (2019-2024)
2.3 Key Companies Visceral Pain Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Visceral Pain Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Visceral Pain Treatment
2.6 Visceral Pain Treatment Market Competitive Analysis
2.6.1 Visceral Pain Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Visceral Pain Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Visceral Pain Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 HS-665
3.1.2 CC-8464
3.1.3 BLU-5937
3.1.4 APD-371
3.1.5 Others
3.2 Global Visceral Pain Treatment Sales Value by Type
3.2.1 Global Visceral Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Visceral Pain Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Visceral Pain Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 In-patient
4.1.2 Out-patient
4.2 Global Visceral Pain Treatment Sales Value by Application
4.2.1 Global Visceral Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Visceral Pain Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Visceral Pain Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Visceral Pain Treatment Sales Value by Region
5.1.1 Global Visceral Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Visceral Pain Treatment Sales Value by Region (2019-2024)
5.1.3 Global Visceral Pain Treatment Sales Value by Region (2025-2030)
5.1.4 Global Visceral Pain Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Visceral Pain Treatment Sales Value, 2019-2030
5.2.2 North America Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Visceral Pain Treatment Sales Value, 2019-2030
5.3.2 Europe Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Visceral Pain Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Visceral Pain Treatment Sales Value, 2019-2030
5.5.2 South America Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Visceral Pain Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Visceral Pain Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Visceral Pain Treatment Sales Value
6.3 United States
6.3.1 United States Visceral Pain Treatment Sales Value, 2019-2030
6.3.2 United States Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Visceral Pain Treatment Sales Value, 2019-2030
6.4.2 Europe Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Visceral Pain Treatment Sales Value, 2019-2030
6.5.2 China Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Visceral Pain Treatment Sales Value, 2019-2030
6.6.2 Japan Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Visceral Pain Treatment Sales Value, 2019-2030
6.7.2 South Korea Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Visceral Pain Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Visceral Pain Treatment Sales Value, 2019-2030
6.9.2 India Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Addex Therapeutics Ltd
7.1.1 Addex Therapeutics Ltd Profile
7.1.2 Addex Therapeutics Ltd Main Business
7.1.3 Addex Therapeutics Ltd Visceral Pain Treatment Products, Services and Solutions
7.1.4 Addex Therapeutics Ltd Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Addex Therapeutics Ltd Recent Developments
7.2 Astellas Pharma Inc.
7.2.1 Astellas Pharma Inc. Profile
7.2.2 Astellas Pharma Inc. Main Business
7.2.3 Astellas Pharma Inc. Visceral Pain Treatment Products, Services and Solutions
7.2.4 Astellas Pharma Inc. Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Astellas Pharma Inc. Recent Developments
7.3 Chromocell Corporation
7.3.1 Chromocell Corporation Profile
7.3.2 Chromocell Corporation Main Business
7.3.3 Chromocell Corporation Visceral Pain Treatment Products, Services and Solutions
7.3.4 Chromocell Corporation Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 GIcare Pharma Inc Recent Developments
7.4 GIcare Pharma Inc
7.4.1 GIcare Pharma Inc Profile
7.4.2 GIcare Pharma Inc Main Business
7.4.3 GIcare Pharma Inc Visceral Pain Treatment Products, Services and Solutions
7.4.4 GIcare Pharma Inc Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 GIcare Pharma Inc Recent Developments
7.5 Grunenthal GmbH
7.5.1 Grunenthal GmbH Profile
7.5.2 Grunenthal GmbH Main Business
7.5.3 Grunenthal GmbH Visceral Pain Treatment Products, Services and Solutions
7.5.4 Grunenthal GmbH Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Grunenthal GmbH Recent Developments
7.6 Medestea Research & Production S.p.A.
7.6.1 Medestea Research & Production S.p.A. Profile
7.6.2 Medestea Research & Production S.p.A. Main Business
7.6.3 Medestea Research & Production S.p.A. Visceral Pain Treatment Products, Services and Solutions
7.6.4 Medestea Research & Production S.p.A. Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Medestea Research & Production S.p.A. Recent Developments
7.7 Neurim Pharmaceuticals Ltd
7.7.1 Neurim Pharmaceuticals Ltd Profile
7.7.2 Neurim Pharmaceuticals Ltd Main Business
7.7.3 Neurim Pharmaceuticals Ltd Visceral Pain Treatment Products, Services and Solutions
7.7.4 Neurim Pharmaceuticals Ltd Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Neurim Pharmaceuticals Ltd Recent Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Profile
7.8.2 Pfizer Inc. Main Business
7.8.3 Pfizer Inc. Visceral Pain Treatment Products, Services and Solutions
7.8.4 Pfizer Inc. Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Pfizer Inc. Recent Developments
8 Industry Chain Analysis
8.1 Visceral Pain Treatment Industrial Chain
8.2 Visceral Pain Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Visceral Pain Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Visceral Pain Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Visceral Pain Treatment Product Introduction
1.2 Global Visceral Pain Treatment Market Size Forecast
1.3 Visceral Pain Treatment Market Trends & Drivers
1.3.1 Visceral Pain Treatment Industry Trends
1.3.2 Visceral Pain Treatment Market Drivers & Opportunity
1.3.3 Visceral Pain Treatment Market Challenges
1.3.4 Visceral Pain Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Visceral Pain Treatment Players Revenue Ranking (2023)
2.2 Global Visceral Pain Treatment Revenue by Company (2019-2024)
2.3 Key Companies Visceral Pain Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Visceral Pain Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Visceral Pain Treatment
2.6 Visceral Pain Treatment Market Competitive Analysis
2.6.1 Visceral Pain Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Visceral Pain Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Visceral Pain Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 HS-665
3.1.2 CC-8464
3.1.3 BLU-5937
3.1.4 APD-371
3.1.5 Others
3.2 Global Visceral Pain Treatment Sales Value by Type
3.2.1 Global Visceral Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Visceral Pain Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Visceral Pain Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 In-patient
4.1.2 Out-patient
4.2 Global Visceral Pain Treatment Sales Value by Application
4.2.1 Global Visceral Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Visceral Pain Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Visceral Pain Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Visceral Pain Treatment Sales Value by Region
5.1.1 Global Visceral Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Visceral Pain Treatment Sales Value by Region (2019-2024)
5.1.3 Global Visceral Pain Treatment Sales Value by Region (2025-2030)
5.1.4 Global Visceral Pain Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Visceral Pain Treatment Sales Value, 2019-2030
5.2.2 North America Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Visceral Pain Treatment Sales Value, 2019-2030
5.3.2 Europe Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Visceral Pain Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Visceral Pain Treatment Sales Value, 2019-2030
5.5.2 South America Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Visceral Pain Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Visceral Pain Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Visceral Pain Treatment Sales Value
6.3 United States
6.3.1 United States Visceral Pain Treatment Sales Value, 2019-2030
6.3.2 United States Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Visceral Pain Treatment Sales Value, 2019-2030
6.4.2 Europe Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Visceral Pain Treatment Sales Value, 2019-2030
6.5.2 China Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Visceral Pain Treatment Sales Value, 2019-2030
6.6.2 Japan Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Visceral Pain Treatment Sales Value, 2019-2030
6.7.2 South Korea Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Visceral Pain Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Visceral Pain Treatment Sales Value, 2019-2030
6.9.2 India Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Visceral Pain Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Addex Therapeutics Ltd
7.1.1 Addex Therapeutics Ltd Profile
7.1.2 Addex Therapeutics Ltd Main Business
7.1.3 Addex Therapeutics Ltd Visceral Pain Treatment Products, Services and Solutions
7.1.4 Addex Therapeutics Ltd Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Addex Therapeutics Ltd Recent Developments
7.2 Astellas Pharma Inc.
7.2.1 Astellas Pharma Inc. Profile
7.2.2 Astellas Pharma Inc. Main Business
7.2.3 Astellas Pharma Inc. Visceral Pain Treatment Products, Services and Solutions
7.2.4 Astellas Pharma Inc. Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Astellas Pharma Inc. Recent Developments
7.3 Chromocell Corporation
7.3.1 Chromocell Corporation Profile
7.3.2 Chromocell Corporation Main Business
7.3.3 Chromocell Corporation Visceral Pain Treatment Products, Services and Solutions
7.3.4 Chromocell Corporation Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 GIcare Pharma Inc Recent Developments
7.4 GIcare Pharma Inc
7.4.1 GIcare Pharma Inc Profile
7.4.2 GIcare Pharma Inc Main Business
7.4.3 GIcare Pharma Inc Visceral Pain Treatment Products, Services and Solutions
7.4.4 GIcare Pharma Inc Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 GIcare Pharma Inc Recent Developments
7.5 Grunenthal GmbH
7.5.1 Grunenthal GmbH Profile
7.5.2 Grunenthal GmbH Main Business
7.5.3 Grunenthal GmbH Visceral Pain Treatment Products, Services and Solutions
7.5.4 Grunenthal GmbH Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Grunenthal GmbH Recent Developments
7.6 Medestea Research & Production S.p.A.
7.6.1 Medestea Research & Production S.p.A. Profile
7.6.2 Medestea Research & Production S.p.A. Main Business
7.6.3 Medestea Research & Production S.p.A. Visceral Pain Treatment Products, Services and Solutions
7.6.4 Medestea Research & Production S.p.A. Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Medestea Research & Production S.p.A. Recent Developments
7.7 Neurim Pharmaceuticals Ltd
7.7.1 Neurim Pharmaceuticals Ltd Profile
7.7.2 Neurim Pharmaceuticals Ltd Main Business
7.7.3 Neurim Pharmaceuticals Ltd Visceral Pain Treatment Products, Services and Solutions
7.7.4 Neurim Pharmaceuticals Ltd Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Neurim Pharmaceuticals Ltd Recent Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Profile
7.8.2 Pfizer Inc. Main Business
7.8.3 Pfizer Inc. Visceral Pain Treatment Products, Services and Solutions
7.8.4 Pfizer Inc. Visceral Pain Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Pfizer Inc. Recent Developments
8 Industry Chain Analysis
8.1 Visceral Pain Treatment Industrial Chain
8.2 Visceral Pain Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Visceral Pain Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Visceral Pain Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Visceral Pain Treatment Market Trends
Table 2. Visceral Pain Treatment Market Drivers & Opportunity
Table 3. Visceral Pain Treatment Market Challenges
Table 4. Visceral Pain Treatment Market Restraints
Table 5. Global Visceral Pain Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Visceral Pain Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Visceral Pain Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Visceral Pain Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Visceral Pain Treatment
Table 10. Global Visceral Pain Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Visceral Pain Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Visceral Pain Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Visceral Pain Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Visceral Pain Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Visceral Pain Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Visceral Pain Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Visceral Pain Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Visceral Pain Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Visceral Pain Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Visceral Pain Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Visceral Pain Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Visceral Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Visceral Pain Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Visceral Pain Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Visceral Pain Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Visceral Pain Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Visceral Pain Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Visceral Pain Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Visceral Pain Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Addex Therapeutics Ltd Basic Information List
Table 32. Addex Therapeutics Ltd Description and Business Overview
Table 33. Addex Therapeutics Ltd Visceral Pain Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Visceral Pain Treatment Business of Addex Therapeutics Ltd (2019-2024)
Table 35. Addex Therapeutics Ltd Recent Developments
Table 36. Astellas Pharma Inc. Basic Information List
Table 37. Astellas Pharma Inc. Description and Business Overview
Table 38. Astellas Pharma Inc. Visceral Pain Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Visceral Pain Treatment Business of Astellas Pharma Inc. (2019-2024)
Table 40. Astellas Pharma Inc. Recent Developments
Table 41. Chromocell Corporation Basic Information List
Table 42. Chromocell Corporation Description and Business Overview
Table 43. Chromocell Corporation Visceral Pain Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Visceral Pain Treatment Business of Chromocell Corporation (2019-2024)
Table 45. Chromocell Corporation Recent Developments
Table 46. GIcare Pharma Inc Basic Information List
Table 47. GIcare Pharma Inc Description and Business Overview
Table 48. GIcare Pharma Inc Visceral Pain Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Visceral Pain Treatment Business of GIcare Pharma Inc (2019-2024)
Table 50. GIcare Pharma Inc Recent Developments
Table 51. Grunenthal GmbH Basic Information List
Table 52. Grunenthal GmbH Description and Business Overview
Table 53. Grunenthal GmbH Visceral Pain Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Visceral Pain Treatment Business of Grunenthal GmbH (2019-2024)
Table 55. Grunenthal GmbH Recent Developments
Table 56. Medestea Research & Production S.p.A. Basic Information List
Table 57. Medestea Research & Production S.p.A. Description and Business Overview
Table 58. Medestea Research & Production S.p.A. Visceral Pain Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Visceral Pain Treatment Business of Medestea Research & Production S.p.A. (2019-2024)
Table 60. Medestea Research & Production S.p.A. Recent Developments
Table 61. Neurim Pharmaceuticals Ltd Basic Information List
Table 62. Neurim Pharmaceuticals Ltd Description and Business Overview
Table 63. Neurim Pharmaceuticals Ltd Visceral Pain Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Visceral Pain Treatment Business of Neurim Pharmaceuticals Ltd (2019-2024)
Table 65. Neurim Pharmaceuticals Ltd Recent Developments
Table 66. Pfizer Inc. Basic Information List
Table 67. Pfizer Inc. Description and Business Overview
Table 68. Pfizer Inc. Visceral Pain Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Visceral Pain Treatment Business of Pfizer Inc. (2019-2024)
Table 70. Pfizer Inc. Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. Visceral Pain Treatment Downstream Customers
Table 74. Visceral Pain Treatment Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Visceral Pain Treatment Product Picture
Figure 2. Global Visceral Pain Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Visceral Pain Treatment Report Years Considered
Figure 5. Global Visceral Pain Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Visceral Pain Treatment Revenue in 2023
Figure 7. Visceral Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. HS-665 Picture
Figure 9. CC-8464 Picture
Figure 10. BLU-5937 Picture
Figure 11. APD-371 Picture
Figure 12. Others Picture
Figure 13. Global Visceral Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Visceral Pain Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of In-patient
Figure 16. Product Picture of Out-patient
Figure 17. Global Visceral Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Visceral Pain Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Visceral Pain Treatment Sales Value (%), (2019-2030)
Figure 30. United States Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 36. China Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 38. China Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. India Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. India Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. Visceral Pain Treatment Industrial Chain
Figure 52. Visceral Pain Treatment Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. Visceral Pain Treatment Market Trends
Table 2. Visceral Pain Treatment Market Drivers & Opportunity
Table 3. Visceral Pain Treatment Market Challenges
Table 4. Visceral Pain Treatment Market Restraints
Table 5. Global Visceral Pain Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Visceral Pain Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Visceral Pain Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Visceral Pain Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Visceral Pain Treatment
Table 10. Global Visceral Pain Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Visceral Pain Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Visceral Pain Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Visceral Pain Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Visceral Pain Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Visceral Pain Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Visceral Pain Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Visceral Pain Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Visceral Pain Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Visceral Pain Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Visceral Pain Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Visceral Pain Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Visceral Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Visceral Pain Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Visceral Pain Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Visceral Pain Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Visceral Pain Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Visceral Pain Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Visceral Pain Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Visceral Pain Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Addex Therapeutics Ltd Basic Information List
Table 32. Addex Therapeutics Ltd Description and Business Overview
Table 33. Addex Therapeutics Ltd Visceral Pain Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Visceral Pain Treatment Business of Addex Therapeutics Ltd (2019-2024)
Table 35. Addex Therapeutics Ltd Recent Developments
Table 36. Astellas Pharma Inc. Basic Information List
Table 37. Astellas Pharma Inc. Description and Business Overview
Table 38. Astellas Pharma Inc. Visceral Pain Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Visceral Pain Treatment Business of Astellas Pharma Inc. (2019-2024)
Table 40. Astellas Pharma Inc. Recent Developments
Table 41. Chromocell Corporation Basic Information List
Table 42. Chromocell Corporation Description and Business Overview
Table 43. Chromocell Corporation Visceral Pain Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Visceral Pain Treatment Business of Chromocell Corporation (2019-2024)
Table 45. Chromocell Corporation Recent Developments
Table 46. GIcare Pharma Inc Basic Information List
Table 47. GIcare Pharma Inc Description and Business Overview
Table 48. GIcare Pharma Inc Visceral Pain Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Visceral Pain Treatment Business of GIcare Pharma Inc (2019-2024)
Table 50. GIcare Pharma Inc Recent Developments
Table 51. Grunenthal GmbH Basic Information List
Table 52. Grunenthal GmbH Description and Business Overview
Table 53. Grunenthal GmbH Visceral Pain Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Visceral Pain Treatment Business of Grunenthal GmbH (2019-2024)
Table 55. Grunenthal GmbH Recent Developments
Table 56. Medestea Research & Production S.p.A. Basic Information List
Table 57. Medestea Research & Production S.p.A. Description and Business Overview
Table 58. Medestea Research & Production S.p.A. Visceral Pain Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Visceral Pain Treatment Business of Medestea Research & Production S.p.A. (2019-2024)
Table 60. Medestea Research & Production S.p.A. Recent Developments
Table 61. Neurim Pharmaceuticals Ltd Basic Information List
Table 62. Neurim Pharmaceuticals Ltd Description and Business Overview
Table 63. Neurim Pharmaceuticals Ltd Visceral Pain Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Visceral Pain Treatment Business of Neurim Pharmaceuticals Ltd (2019-2024)
Table 65. Neurim Pharmaceuticals Ltd Recent Developments
Table 66. Pfizer Inc. Basic Information List
Table 67. Pfizer Inc. Description and Business Overview
Table 68. Pfizer Inc. Visceral Pain Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Visceral Pain Treatment Business of Pfizer Inc. (2019-2024)
Table 70. Pfizer Inc. Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. Visceral Pain Treatment Downstream Customers
Table 74. Visceral Pain Treatment Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Visceral Pain Treatment Product Picture
Figure 2. Global Visceral Pain Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Visceral Pain Treatment Report Years Considered
Figure 5. Global Visceral Pain Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Visceral Pain Treatment Revenue in 2023
Figure 7. Visceral Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. HS-665 Picture
Figure 9. CC-8464 Picture
Figure 10. BLU-5937 Picture
Figure 11. APD-371 Picture
Figure 12. Others Picture
Figure 13. Global Visceral Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Visceral Pain Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of In-patient
Figure 16. Product Picture of Out-patient
Figure 17. Global Visceral Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Visceral Pain Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Visceral Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Visceral Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Visceral Pain Treatment Sales Value (%), (2019-2030)
Figure 30. United States Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 36. China Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 38. China Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. India Visceral Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Visceral Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. India Visceral Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. Visceral Pain Treatment Industrial Chain
Figure 52. Visceral Pain Treatment Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232